Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Additional Paid-in Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Non-controlling Interests
Balance at beginning of period (in shares) at Dec. 31, 2024		168.6
Balance at beginning of period at Dec. 31, 2024		$ 1,942	$ (2,539)	$ 2,300	$ 16
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	$ 432			430	2
Other comprehensive income (loss)	39		39
Issuance of common stock and stock options exercised (in shares)		0.7
Issuance of common stock and stock options exercised		$ (90)
Share repurchase program (in shares)		(0.7)
Share repurchase program				(325)
Share-based compensation expenses		$ 66
Dividends declared				(182)
Balance at ending of period (in shares) at Mar. 29, 2025		168.6
Balance at end of period at Mar. 29, 2025		$ 1,918	(2,500)	2,223	18
Balance at beginning of period (in shares) at Dec. 31, 2025		167.4
Balance at beginning of period at Dec. 31, 2025	2,427	$ 2,281	(2,420)	2,549	17
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net earnings	368			366	2
Other comprehensive income (loss)	$ (3)		(3)
Issuance of common stock and stock options exercised (in shares)		1.0
Issuance of common stock and stock options exercised		$ (8)
Share repurchase program (in shares)	(0.3)	(0.3)
Share repurchase program	$ (118)			(118)
Share-based compensation expenses		$ 98
Dividends declared				(201)
Balance at ending of period (in shares) at Apr. 04, 2026		168.1
Balance at end of period at Apr. 04, 2026	$ 2,563	$ 2,371	$ (2,423)	$ 2,596	$ 19